MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
2.850
-0.040
-1.38%
After Hours: 3.060 +0.21 +7.37% 18:48 03/06 EST
OPEN
2.930
PREV CLOSE
2.890
HIGH
2.976
LOW
2.800
VOLUME
87.99K
TURNOVER
--
52 WEEK HIGH
5.46
52 WEEK LOW
2.331
MARKET CAP
95.13M
P/E (TTM)
-8.4645
1D
5D
1M
3M
1Y
5Y
1D
Anixa Biosciences to Host Virtual 2026 Annual Meeting of Stockholders and Corporate Update
Reuters · 4d ago
ANIXA BIOSCIENCES TO HOST 2026 ANNUAL MEETING OF STOCKHOLDERS AND PROVIDE CORPORATE UPDATE HIGHLIGHTING RECENT CLINICAL AND REGULATORY PROGRESS
Reuters · 4d ago
Weekly Report: what happened at ANIX last week (0223-0227)?
Weekly Report · 4d ago
Anixa Biosciences to Spotlight Lira-cel Phase 1 Trial at SCTR Institute 2026 Retreat
Reuters · 02/23 13:55
Weekly Report: what happened at ANIX last week (0216-0220)?
Weekly Report · 02/23 10:22
Weekly Report: what happened at ANIX last week (0209-0213)?
Weekly Report · 02/16 10:22
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and BeOne Medicines (ONC)
TipRanks · 02/09 17:00
Anixa Advances Ovarian Cancer CAR-T With Higher Dosing
TipRanks · 02/09 13:49
More
About ANIX
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.